Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

CNY 6.25

(-1.88%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.44 Billion 3.57 Billion 4.21 Billion 4.68 Billion 1.52 Billion 2.08 Billion
Total Current Assets 2.12 Billion 1.74 Billion 2.05 Billion 2.11 Billion 1.09 Billion 1.04 Billion
Cash And Short Term Investments 15.2 Million 17.47 Million 107.69 Million 139.91 Million 409.29 Million 357.64 Million
Cash and Cash Equivalents 15.2 Million 17.47 Million 107.69 Million 139.41 Million 409.29 Million 357.64 Million
Short Term Investments - - - 500 Thousand - -
Net Receivables 1.64 Billion 1.6 Billion 1.69 Billion 1.69 Billion 486.44 Million 478.5 Million
Inventory 51.85 Million 59.47 Million 195.34 Million 251.6 Million 188.06 Million 201.19 Million
Other Current Assets 50.44 Million 57.24 Million 56.44 Million 28.17 Million 10.2 Million 3.75 Million
Total Non-Current Assets 1.31 Billion 1.83 Billion 2.15 Billion 2.56 Billion 429.12 Million 1.04 Billion
Net PPE 960.44 Million 1.07 Billion 1.3 Billion 1.16 Billion 313.84 Million 341.68 Million
Good Will And Intangible Assets 335.25 Million 717.17 Million 764.4 Million 774.63 Million 63.88 Million 653.55 Million
Good Will 236.06 Million 675.42 Million 701.73 Million 701.73 Million - 581.47 Million
Intangible Assets 99.18 Million 41.74 Million 62.67 Million 72.9 Million 63.88 Million 72.07 Million
Long-Term Investments 1.94 Million 2.46 Million 15.57 Million 17.49 Million 2.00 18.62 Million
Tax Assets 16.46 Million 39.8 Million 66.21 Million 52.96 Million 32.13 Million 24.92 Million
Other Non Current Assets 3.02 Million 1.69 Million 5.07 Million 559.13 Million 19.26 Million 4.35 Million
Other Assets - 1.00 - 1.00 - -
Total Liabilities 2.42 Billion 1.91 Billion 2.6 Billion 3.23 Billion 771.18 Million 652.6 Million
Total Current Liabilities 1.88 Billion 1.54 Billion 2.1 Billion 2.62 Billion 743.99 Million 624.2 Million
Account Payables 358.5 Million 199.55 Million 642.86 Million 604.19 Million 429.81 Million 283.71 Million
Tax Payables 127.46 Million 132.2 Million 124.41 Million 108.32 Million 25.62 Million 23.38 Million
Short Term Debt 313.14 Million 609 Million 526.7 Million 567.19 Million 234.5 Million 274.5 Million
Deferred Revenue 1.2 Billion 734.9 Million 936.49 Million 1.45 Billion 65.36 Million 55.05 Million
Other Current Liabilities 1.72 Million 1.58 Million 3.85 Million 4.2 Million 14.31 Million 10.93 Million
Total Non Current Liabilities 548.01 Million 368.91 Million 495.26 Million 606.62 Million 27.19 Million 28.4 Million
Long-Term Debt 524.33 Million 341.26 Million 331.69 Million 340 Million 1.00 1.00
Deferred Revenue Non Current 15.24 Million 15.9 Million 23.71 Million 26.08 Million 10.76 Million 12.67 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.32 Million 4.64 Million 131.14 Million 229.6 Million 12.26 Million 10.68 Million
Other Liabilities 1.00 1.00 - - 1.00 1.00
Total Equity 1.01 Billion 1.66 Billion 1.6 Billion 1.44 Billion 751.94 Million 1.43 Billion
Stock Holders Equity 195.12 Million 800.67 Million 826.28 Million 776.69 Million 757.85 Million 1.43 Billion
Common Stock 350.33 Million 350.33 Million 350.33 Million 350.33 Million 350.33 Million 233.55 Million
Retained Earnings -961.74 Million -356.09 Million -332.81 Million -381.92 Million -407.24 Million 274.13 Million
Accumulated other comprehensive income - 18.35 Million 20.69 Million 20.21 Million 26.69 Million 22.59 Million
Common Stock Equity 195.12 Million 800.67 Million 826.28 Million 776.69 Million 757.85 Million 1.43 Billion
Capital Lease Obligation 5.45 Million 5.97 Million 21.14 Million 5.1 Million - -
Total Investments 1.94 Million 2.46 Million 15.57 Million 500 Thousand 2.00 18.62 Million
Total Debt 837.48 Million 950.27 Million 858.4 Million 907.19 Million 234.5 Million 274.5 Million
Net Debt 822.28 Million 932.79 Million 750.7 Million 767.77 Million -174.79 Million -83.14 Million

Balance Sheet Charts